PA
NGNE icon

Perceptive Advisors’s Neurogene NGNE Stock Holding History

Perceptive Advisors’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26,871
Closed -$8.92M – 140
2020
Q2 		$8.92M Buy
26,871
+1,871
+7% +$488K 0.14% 84
2020
Q1 		$5.54M Hold
25,000
– – 0.14% 75
2019
Q4 		$6.16M Buy
+25,000
New +$2.49M 0.12% 75
2016
Q2 		– Sell
-2,980
Closed -$526K – 194
2016
Q1 		$526K Hold
2,980
– – 0.05% 116
2015
Q4 		$744K Hold
2,980
– – 0.06% 92
2015
Q3 		$839K Sell
2,980
-3,520
-54% -$811K 0.07% 100
2015
Q2 		$902K Hold
6,500
– – 0.05% 121
2015
Q1 		$1.11M Hold
6,500
– – 0.09% 100
2014
Q4 		$975K Hold
6,500
– – 0.08% 103
2014
Q3 		$866K Hold
6,500
– – 0.09% 87
2014
Q2 		$1.22M Hold
6,500
– – 0.12% 76
2014
Q1 		$1.66M Buy
+6,500
New +$1.67M 0.17% 74

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors's NGNE Position: Q3 2020 in Review

Perceptive Advisors sold out of Neurogene (NGNE) in Q3 2020, closing a stake of 26,871 shares — an estimated $8.92M sold.

Perceptive Advisors first reported a position in NGNE in Q1 2014 and held it in 12 quarters. The position peaked at $8.92M in Q2 2020. 81 funds tracked by Wall St. Rank hold NGNE as of Q3 2020.

  • Perceptive Advisors reported no remaining Neurogene position as of Q3 2020 after selling out during the quarter.
  • Perceptive Advisors sold 26,871 Neurogene shares in Q3 2020, an estimated $8.92M.
  • Perceptive Advisors first reported a position in Neurogene in Q1 2014 and held it in 12 quarters.
  • Perceptive Advisors's Neurogene position peaked at $8.92M in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Neurogene as of Q3 2020.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.